Resources Investment Advisors, Llc. Clovis Oncology, Inc. Transaction History

Resources Investment Advisors, Llc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$4.13 - $6.41 $29,529 - $45,831	-7,150 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$4.82 - $7.72 $20,518 - $32,864	-4,257 Reduced 37.32%	7,150 $41,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $8,517 - $14,505	1,497 Added 15.11%	11,407 $76,000
Q1 2020 May 14, 2020	SELL	$3.77 - $11.0 $11,634 - $33,946	-3,086 Reduced 23.75%	9,910 $63,000
Q4 2019 Feb 07, 2020	BUY	$3.0 - $16.43 $38,988 - $213,524	12,996 New	12,996 $135,000
Q2 2018 Aug 15, 2018	SELL	$42.06 - $62.4 $12,618 - $18,720	-300 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$50.12 - $67.72 $15,036 - $20,316	300 New	300 $16,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.